Scientific innovati你做on
strategy
strategy
Overall Strategy
To insist on the investment in medi村東cal technology innovation, a日關scertainstrategic management and con妹快trol mode, implements the indust厭就rial strategy wi錯舞th biopharmaceutical indust什房ry as the primary and re妹筆al estate industry as the su讀海pplement, advance the coo歌章perative process of internat志什ional projects in line 雨理with the developm低開ental principle of ‘‘sufficient樂暗 stock and high yield分外 with fine quality ’’ and on the b火西asis of highly marketable農我 mechanism, create ‘‘five big developme聽線nt platforms’’ for ge是高netic engineering pharmaceuticals, n土站ew-type vaccines,一看 antibody drugs, chemical medici樹南nes and modern tradi數這tional Chinese m不志edicine, enhance the control, 房個influence and contribution force of議湖 ‘‘CCHT’’ in domestic pharmaceut國要ical field, and make it stro暗水nger before make it bigger.
Core Competence
Resource Integration Ability月好 Resource I我藍ntegration Ability ‘‘CCHT’’ 理女utilizes industrial info嗎內rmation resources, cutting-edge te麗時chnologies and high是那-end talent resource時農s to integrate internal a票下nd external reso要們urces of the enterprise to form a comp了業etitive force. |
Scientific and Technological Content個很 of Products他聽 ‘‘CCHT’’ i票長s an international le水農ader in the research of growt我大h hormone series pr歌視oducts and a domestic leader in對看 the research field體河s of follicle-stimulating hormo美黃ne, varicella vac雜劇cine, nasal spray influenza vaccine and算雜 rabies vaccine. |
Market Network木影 After yea照公rs of market operation, its sever討鄉al pharmaceutical吧劇 companies have formed a mature mar舞水ket network with a務那 certain scale. |
Brand Image器數 The products and 公了brands of Gensci and BCHT have時頻 a high repatation in自身 China. |
Financing Ability機間 The performance of ‘了這‘CCHT’’ has increased substantially 得遠for several consecutive years 街但and it has been qualified for financ東海ing; ‘‘CCHT’’ sets up techn海飛ical platforms to lay the foun日遠dation for the introduction of行民 new projects; ‘‘呢煙CCHT’’ has successful pr東車oject investment 快黃experiences. |
Research & Development A舊年bility如山 In recent years, ‘‘CCHT’’ 是黃has invested heavily and has built a d低化omestic first-class research & dev空唱elopment platform for genet小國ic engineering pharmaceutica你習ls, biological vaccines and訊山 modern tradition刀你al Chinese medi要綠cine with abunda小來nt reserves of varieties u影鐘nder research. 大現 |
Management innovation
strategy
strategy
Through the common value c麗線oncept and the assets as the link,山歌 CCHT integrates related resources wi請得th moderate diversification, to achi信風eve the maximizatio銀討n of shareholders' 風明equity and benefits. In line with the 機小organizational dev到家elopment directio體那n of "small headquarter, big com秒跳pany", the group headqu民員arter is built into five centers--a st紙藍rategic decision-ma術木king center, capital operation 友湖center, brand management center相資, financial control center, talent討愛 development center. According to近又 the positioning of different bu月機siness units and說見 equity of branches and subs匠又idiaries in the group,做錯 CCHT further improves the sc他件ientific collectivization manage習站ment and control model.
To establish innovative re那火search and development as the m算愛ain body, supplemented by i謝電nnovative developme兒請nt strategies with techno電紅logical innovation, technological tran近家sformation, and product u少有pgrading, CCHT will increase invest照到ment in research and de月站velopment, continuously improve the in鐘內novation system and capabiliti化多es.
To integrate the technology researc北得h and development syste又高m from a strategic height continuou知如sly, emphasize on the rese務他arch and development an是購d incubation of new technolo哥來gies and products, and continuously 能間enrich and optimize produ高跳ct line, CCHT will s從裡trive for the sust山亮ainability of med藍體ium and long-term pro但廠duct line layout of the company, 數討and build a product echelon t鐵還hat supports the health develop去銀ment of the company.
Through the "intensive f文車arming" strategy, CCHT will pro用不mote the existing products to 窗商continuously streng藍音then market penetra習件tion and increase market covera短時ge; through the continuous intr作員oduction of new products, 放購including imitation or mod討聽ification of dosage錯購 forms, CCHT will achiev學票e protection of exis愛到ting varieties, supplement湖做 existing indications of blank匠樹 market segments and enter 購訊into new indications銀時.
Internationalizat房著ion
strategy
strategy
The world is accelerating towa議頻rds China, and Chin少費a is fully integrated into the 女作world. Taking advantage of the風請 economic globalization, CCHT ac北習tively explores a new path for int相銀ernational cooperation w作是ith an attitude of openness, incl吃紙usiveness, co-construction and文新 sharing, and inclusiveness, and leapf麗費rog towards internationalization in se水機lf-reform.
The first is to steadily develop exi農通sting industries and to些廠 do well preparation睡道 of accumulating capital and technology河妹.
To ensure the steady growth of the d刀黃omestic market for existing core能區 products, and provide powerful bene笑山fit support for the internati音就onalization of enterprises; to co道校ntinuously improve the manufact內河uring level of 商視existing core products從個, and fully integra著業te with international sta紙站ndards in terms of production techno黑中logy, manufacturing processes and 化錯product quality; to d舊現evelop international 花技high-end markets湖鄉 certification and registrat校說ion to lay the fou現拿ndation for nat秒還ionalization. Due to the special a嗎報ttributes of the pharmaceutical indus們去try, there are higher 器也requirements in intern機山ational certification and sup北信ervision, especially i區對n the high-end markets such國間 as the United States, Europe, 我小and Japan, however this is th科懂e only way to enter the national ma他兒rket.
The second is to act通暗ively promote the i城樹nternationalizatio服兵n of research and deve慢喝lopment.
In order to promote the internationali習業zation of the group, the tentacles s高匠hould be deepened into the 海雜global pharmaceut跳公ical research and devel刀亮opment field. CCHT would g音司rasp the recent progress in medic飛新al science and technol報做ogy, especially in deve遠花loped countries and regions in E高商urope and the Unit木學ed States, which has advanced medi匠就cal technology and in-depth basi你中c research results. Through various a商年pproaches such as j的地oint research and d暗下evelopment, purchasi民煙ng of patented techn做下ology, and establishing joint 舊我ventures, CCHT wou那話ld introduce senior overseas talents, 光草focus on improving the Group'報哥;s R & D capabilities in s離舞pecific fields, introduce internationa公匠lly leading new drug p兒請rojects with independent intelle銀又ctual property rig謝員hts, and develop products r腦聽equired by the marke村拿t, to align research and development l議子evel of the group in spe媽筆cific pharmaceutical fi筆開elds with international sta民刀ndards. If there 林熱is a suitable new drug project, CCHT ca他黑n prepare for its applicati城信on for new drug registration in th村們e United States an子他d Europe.
The international mark家年et is complicate跳匠d, and there are macro pol下嗎itical and economic 機場risks. Since different countries als服現o have different access system小鐘s, therefore, the internationa技民l development of th林黑e group needs to study and analyze mark睡厭et demand and rules 木我seriously, pays attention to匠湖 grasp the rhythm, and adva術兒nces steadily.